Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

NICE recommends avelumab for urothelial cancer patients

April 13, 2022 Research and Development

NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …
News

FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall

April 13, 2022 Research and Development

The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …
News

It could take up to six years to clear the patient backlog in Europe

April 13, 2022 Research and Development

Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …
News

Nine more COVID-19 symptoms added to list

April 6, 2022 Research and Development

Nine new symptoms, including sore throat, fatigue, and headache, have been added to the official list of COVID-19 symptoms on …
News

UK Government accused of failing to address cancer staff shortages

April 6, 2022 Research and Development

MPs have warned that urgent steps are needed to prevent the UK from losing gains made in recent years on …
News

New variant, Omicron XE, detected in UK

April 6, 2022 Research and Development

A new sub-variant of Omicron has been found in the UK, as the country experiences a new surge of COVID-19.The …
News

Race to deliver HIV drugs to Ukraine

April 6, 2022 Research and Development

WHO is to supply thousands of antiretroviral drugs to Ukraine for patients living with HIV over the next year. UNAIDS, …
News
leipzig_skyline

FlyPharma Conference Europe: New dates and location announced

April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
News

Iktos announces a collaboration with Ono for new drug design

March 30, 2022 Research and Development

Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …
News

$24 million in grants to help end HIV epidemic across the globe

March 30, 2022 Research and Development

Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …
News

Study finds COVID-19 may double severe complications in pregnancy

March 23, 2022 Research and Development

A Kaiser Permanente analysis of pregnant patients who tested positive for COVID-19 found more than double the risk of severe …
News

Alnylam sues Moderna and Pfizer over key vaccine ingredient

March 23, 2022 Research and Development

Alnylam Pharmaceuticals, a Cambridge, Massachusetts-based company, has sued Moderna and Pfizer over allegations that the firms used patented nanoparticle technology …
News

ONS says no evidence that COVID-19 vaccines lead to young deaths

March 23, 2022 Research and Development

The Office for National Statistics (ONS) has said that there is no evidence that COVID-19 vaccines have led to an …
News

Pfizer to supply UNICEF oral COVID-19 treatment for low- and middle-income countries

March 23, 2022 Research and Development

Pfizer have announced the signing of a supply agreement with the United Nations Children’s Fund (UNICEF), to deliver up to …
News
guy_photo_2022_002

Ipsen appoints Guy Oliver as General Manager, UK & Ireland

March 21, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ipsen have announced the appointment of Guy Oliver as General Manager of its UK and Ireland affiliate. Guy brings a …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026